MbrlCatalogueTitleDetail

Do you wish to reserve the book?
Integrated systems toxicology identifies TCDD-responsive targets linked to immune dysregulation and treatment response in psoriasis
Integrated systems toxicology identifies TCDD-responsive targets linked to immune dysregulation and treatment response in psoriasis
Hey, we have placed the reservation for you!
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Integrated systems toxicology identifies TCDD-responsive targets linked to immune dysregulation and treatment response in psoriasis
Oops! Something went wrong.
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Title added to your shelf!
Title added to your shelf!
View what I already have on My Shelf.
Oops! Something went wrong.
Oops! Something went wrong.
While trying to add the title to your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Integrated systems toxicology identifies TCDD-responsive targets linked to immune dysregulation and treatment response in psoriasis
Integrated systems toxicology identifies TCDD-responsive targets linked to immune dysregulation and treatment response in psoriasis

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
How would you like to get it?
We have requested the book for you! Sorry the robot delivery is not available at the moment
We have requested the book for you!
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Integrated systems toxicology identifies TCDD-responsive targets linked to immune dysregulation and treatment response in psoriasis
Integrated systems toxicology identifies TCDD-responsive targets linked to immune dysregulation and treatment response in psoriasis
Journal Article

Integrated systems toxicology identifies TCDD-responsive targets linked to immune dysregulation and treatment response in psoriasis

2026
Request Book From Autostore and Choose the Collection Method
Overview
Psoriasis is a chronic immune-mediated inflammatory skin disease driven by dysregulation of the IL-23/IL-17 axis and influenced by genetic and environmental factors. The role and molecular mechanisms of the environmental pollutant dibenzo-p-dioxins, particularly 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), in psoriasis remain unclear. An integrative strategy combining network toxicology, machine learning, bioinformatics analysis, molecular simulation, and keratinocyte qRT-PCR validation was employed to systematically investigate the potential toxicity and molecular mechanisms of TCDD in psoriasis. Eighty-seven overlapping genes were identified between TCDD-related targets and psoriasis-associated genes and were mainly enriched in IL- 17-, chemokine-, MAPK/ ERK-, and GPCR-related signaling pathways. Machine learning identified five core target genes-LCK, MMP9, CXCR2, PTAFR, and CCNB1-which were significantly upregulated in psoriatic lesions, showed strong diagnostic performance within the analyzed datasets, and were associated with local immune infiltration patterns. Structural analyses supported potential interactions between TCDD and these core targets, with CXCR2 showing the most favorable predicted docking score. A 24-h keratinocyte TCDD-response signature showed significant concordance with psoriatic lesional transcriptomes, and keratinocyte qRT-PCR validation showed increased expression of LCK, MMP9, CXCR2, and PTAFR, whereas CCNB1 showed only a modest change. In biologic-therapy cohorts, core genes were downregulated after 12 weeks, and higher baseline MMP9 was associated with poorer clinical improvement and may have potential relevance to treatment response. Our integrative analyses identify TCDD-associated genes and pathways potentially involved in psoriasis immune dysregulation. Structural modeling supports the plausibility of TCDD engaging CXCR2, while transcriptomic concordance and keratinocyte qRT-PCR findings support dysregulation of several core genes in epidermal cells. Baseline MMP9 was associated with week-12 treatment response in biologic-therapy cohorts. Nevertheless, the link between environmental TCDD exposure and psoriasis remains inferential because the study relied mainly on analyses without individual-level exposure data; therefore, further validation in well-designed cohort studies is needed.